Discovering Factors in the Clinical Study Journey of Patients With OCD
- Conditions
- OCDObsessive-Compulsive Disorder
- Registration Number
- NCT05881356
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
This research aims to collect comprehensive data on the clinical trial experience of OCD patients. Its goal is to identify the factors that limit patients' ability to join or complete a trial successfully. Clinical trial participation often favors specific demographic groups, and limited research exists on the impact of trial attributes on participation. Therefore, this study aims to analyze data from various demographic groups and identify any recurring trends that could provide valuable insights for future OCD patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 500
- Ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed.
- Participant has a diagnosis of OCD.
- Willing and able to comply with scheduled visits, treatment schedule, laboratory tests and other requirements of the study.
- Pregnant or lactating woman
- Enrolled in another research study
- Any mental or medical condition that prevents the patient from giving informed consent or participating in the trial
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of participants who decide to enroll in a OCD clinical study. 3 months Number of OCD patients who remain in clinical trial until completion. 12 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Power Life Sciences
🇺🇸San Francisco, California, United States